We are live on
!
Find out more
TG
TLP Group Portfolio holdings
AUM
$6.61M
1-Year Est. Return
12.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.51%
1 Year Est. Return
-12.46%
3 Year Est. Return
+42.65%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.8M
AUM Growth
-$80M
(-55%)
Cap. Flow
-$131M
Cap. Flow
% of AUM
-199.18%
Top 10 Holdings %
Top 10 Hldgs %
49.58%
Holding
538
New
154
Increased
37
Reduced
174
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$7.91M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$888K |
| 3 |
Morgan Stanley
MS
|
+$644K |
| 4 |
Eli Lilly
LLY
|
+$522K |
| 5 |
Franklin Resources
BEN
|
+$368K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AIMT
Aimmune Therapeutics
AIMT
|
+$18.5M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$8.78M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.64M |
| 4 |
Merck
MRK
|
+$637K |
| 5 |
CNX Resources
CNX
|
+$517K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.05% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 5.98% |
| 4 | Real Estate | 5.72% |
| 5 | Consumer Discretionary | 5.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
ResMed
RMD
$27.8B
| $75K | 0.11% |
+723
| New | +$73.2K |
|
127
Bio-Techne
TECH
$11.2B
| $75K | 0.11% |
+2,032
| New | +$77.6K |
|
128
UnitedHealth
UNH
$385B
| $75K | 0.11% |
+305
| New | +$73.2K |
|
|
DRE
129
DELISTED
Duke Realty Corp.
DRE
| $75K | 0.11% |
+2,596
| New | +$71.6K |
|
|
WBC
130
DELISTED
WABCO HOLDINGS INC.
WBC
| $75K | 0.11% |
638
+636
| +31,800% | +$80.9K |
|
|
ANDV
131
DELISTED
Andeavor
ANDV
| $75K | 0.11% |
+571
| New | +$75.2K |
|
132
Arthur J. Gallagher & Co
AJG
$62.2B
| $74K | 0.11% |
1,137
-2,493
| -69% | -$169K |
|
133
Whirlpool
WHR
$2.31B
| $74K | 0.11% |
508
+261
| +106% | +$39.7K |
|
134
Waste Management
WM
$95.3B
| $74K | 0.11% |
905
-2,752
| -75% | -$228K |
|
|
WLL
135
DELISTED
Whiting Petroleum Corporation
WLL
| $74K | 0.11% |
+19
| New | +$65.7K |
|
136
Oracle
ORCL
$346B
| $72K | 0.11% |
1,643
-7,756
| -83% | -$357K |
|
137
PUT
State Street Financial Select Sector SPDR ETF
XLF
$55.1B
| $72K | 0.11% |
113,300
| – | – |
|
138
Nabors Industries
NBR
$1.25B
| $71K | 0.11% |
+221
| New | +$81.1K |
|
139
Quanta Services
PWR
$98.1B
| $71K | 0.11% |
+2,130
| New | +$74.6K |
|
140
Ametek
AME
$55.3B
| $69K | 0.1% |
954
-4,714
| -83% | -$349K |
|
141
Brown-Forman Class B
BF.B
$11.8B
| $68K | 0.1% |
+1,395
| New | +$76.3K |
|
|
CA
142
DELISTED
CA, Inc.
CA
| $68K | 0.1% |
1,906
-4,099
| -68% | -$144K |
|
|
DCH
143
Dauch Corp
DCH
$1.33B
| $66K | 0.1% |
4,210
-1,572
| -27% | -$25.3K |
|
144
NewMarket
NEU
$7.08B
| $66K | 0.1% |
164
-760
| -82% | -$297K |
|
145
Newmont
NEM
$101B
| $64K | 0.1% |
1,697
+1,077
| +174% | +$42.4K |
|
|
VAR
146
DELISTED
Varian Medical Systems, Inc.
VAR
| $64K | 0.1% |
+564
| New | +$67.5K |
|
147
Graco
GGG
$12.9B
| $63K | 0.1% |
1,384
-3,111
| -69% | -$143K |
|
148
Seaboard Corp
SEB
$4.43B
| $63K | 0.1% |
+16
| New | +$64.5K |
|
149
Sun Communities
SUI
$14.8B
| $63K | 0.1% |
645
+307
| +91% | +$28.9K |
|
150
S&P Global
SPGI
$124B
| $62K | 0.09% |
+304
| New | +$60.1K |
|
Similar funds
LAM
SPCP
GZ
RGNCM
FCM
DCM
DAL
SAM
TLP Group's Q2 2018 Portfolio in Review
As of Q2 2018, TLP Group held 538 positions worth $65.8M, down 55% from $146M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
TLP Group withdrew a net $131M in Q2 2018, closing 157 positions and reducing 174 holdings. Its most notable exit was Aimmune Therapeutics, an estimated $18.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
Against the trend, TLP Group opened a new position in Franklin Resources worth $352K.
- TLP Group's largest Q2 2018 buy was Franklin Resources: 10,992 shares worth $352K.
- TLP Group added most to iShares Russell 2000 ETF in Q2 2018, an estimated $7.91M increase.
- TLP Group's biggest Q2 2018 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $8.78M.
- TLP Group fully exited Aimmune Therapeutics in Q2 2018, selling an estimated $18.5M.
- TLP Group's ten largest holdings make up 50% of its $65.8M portfolio in Q2 2018.
- TLP Group opened 154 new positions and closed 157 in Q2 2018.
- TLP Group's portfolio value fell 55% quarter-over-quarter to $65.8M.
Based on TLP Group's 13F filing for Q2 2018, filed 14 Aug 2018.